Cytek Biosciences, Inc. (CTKB)

NMS – Real Time Price. Currency in USD

4.73

-0.01 (-0.21%)

Market open: Aug 12, 2026, 2:14 PM EDT

4.82

+0.08 (1.69%)

Previous after-hours: Aug 11, 2026, 7:55 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

201M

200M

193M

164M

Cost of goods sold

-97M

-89M

-84M

-62M

Gross Profit

104M

111M

109M

102M

Operating expenses (excl. COGS)

-145M

-134M

-136M

-103M

Operating Income

-40M

-23M

-26M

-1M

Non-operating income, total

11M

17M

11M

Pretax income

-30M

-6M

-16M

Equity in earnings

Taxes

-37M

-320K

Non-controlling/minority interest

92K

After tax other income/expense

Net income before discontinued operations

-67M

-6M

-12M

Discontinued operations

Net income

-67M

-6M

-12M

Dilution adjustment

Preferred dividends

Cytek Biosciences, Inc. (CTKB)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Cytek Biosciences, Inc. (CTKB)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Cytek Biosciences, Inc. (CTKB)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Cytek Biosciences, Inc. (CTKB)

Income Statement (Annual)

Income Statement (Annual)